×
For best experience we recommend to activate Javascript in your browser.
GLRa2 antibody (N-Term)
The Rabbit Polyclonal anti-GLRa2 antibody has been validated for WB, IHC, ELISA, IF and ICC. It is suitable to detect GLRa2 in samples from Rat, Human and Mouse.
Catalog No. ABIN7094566
$494.77
Plus shipping costs $50.00
100 μL ABIN7094566
200 μL ABIN7098615
100 μL ABIN7094566
200 μL ABIN7098615
Delivery in 11 to 12 Business Days
Quick Overview for GLRa2 antibody (N-Term) (ABIN7094566)
Target
See all GLRa2 Antibodies
GLRa2
(Glycine Receptor, alpha 2 (GLRa2))
Reactivity
Rat, Human, Mouse
Host
All hosts for GLRa2 antibodies
Rabbit
Clonality
All clonalities for GLRa2 antibodies
Polyclonal
Conjugate
All conjugates for GLRa2 antibodies
This GLRa2 antibody is un-conjugated
Application
All applications for GLRa2 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF), Immunocytochemistry (ICC)
Product Details anti-GLRa2 Antibody
(hide)
Binding Specificity
All epitopes for GLRa2 antibodies
N-Term
Specificity
GLRA2 Antibody detects endogenous levels of total GLRA2.
Predicted Reactivity
Pig,Bovine,Horse,Sheep,Rabbit,Dog
Immunogen
A synthesized peptide derived from human GLRA2, corresponding to a region within N-terminal amino acids.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
WB 1:500-1:2000, IF/ICC 1:100-1:500, IHC 1:50-1:200, ELISA(peptide) 1:20000-1:40000
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
Store at -20 °C. Stable for 12 months from date of receipt.
Expiry Date
12 months
Target Details for GLRa2
(hide)
Target
GLRa2
(Glycine Receptor, alpha 2 (GLRa2))
Alternative Name
GLRA2
Gene ID
2742
UniProt
P23416
Pathways
Synaptic Membrane
Recently viewed
(hide)
Chat with us , powered by LiveChat